PHENYLIMIDAZOLVERBINDUNGEN

European patent · EP2394996 · In force

Register entry

Publication number
EP2394996
Application number
EP10738531
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Feb 3, 2010
Published
Dec 14, 2011
Granted
Jun 22, 2016
Protection ends at the latest
Feb 2, 2030
Next annual fee due
Feb 28, 2027
IPC classes
C07D 233/64 (2006.01)
A61K 31/4164 (2006.01)
A61K 31/4178 (2006.01)
A61P 3/04 (2006.01)
A61P 3/06 (2006.01)
A61P 9/10 (2006.01)
A61P 43/00 (2006.01)
C07D 405/04 (2006.01)
C07D 409/04 (2006.01)
C07D 233/54 (2006.01)
Priority
JP 2009023793 04.02.2009
JP 2009255980 09.11.2009
PCT application
PCT/JP2010/051469 03.02.2010
PCT publication
WO2010/090200 12.08.2010
Filing language
Japanese
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Mar 1, 2026

    Change

    Published in Swissreg on 01.03.2026

  2. Mar 1, 2025

    Change

    Published in Swissreg on 01.03.2025

  3. Mar 1, 2024

    Change

    Published in Swissreg on 01.03.2024

  4. Mar 6, 2023

    Change

    Published in Swissreg on 06.03.2023

  5. Aug 9, 2016

    Address changed

    Owner
    Otsuka Pharmaceutical Factory, Inc., 115, Aza-Kuguhara,, Tateiwa,, Muya-cho,, Naruto-shi, Tokushima 772-8601, Japan → Otsuka Pharmaceutical Factory, Inc., 115 Aza Kuguhara, Tateiwa, Muya-cho, Naruto-shi, Tokushima 7728601, Japan

    Published in Swissreg on 09.08.2016

  6. Jun 22, 2016

    Granted

    Published in Swissreg on 22.06.2016

Parties

Inventor

SHIBUTANI, Tadao

Naruto-shi Tokushima 772-8601, JP

IWATA, Koushi

Naruto-shi Tokushima 772-8601, JP

KIDO, Satoshi

Naruto-shi Tokushima 772-8601, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.